PHILADELPHIA, PA, USA (UroToday.com) - This analysis set forth to determine the onset and number of consecutive dry days and reductions of UI episodes (IEs) provided by darifenacin, using pooled data from 3 phase III studies (multicenter, randomized, double-blind, placebo-controlled 12-week studies with darifenacin of fixed-doses of 7.5 and 15 mg once daily).
Your session will expire in 8 hours requiring you to log in each day to view content.